This NDC is on FDA's drug shortage list (posted Feb 22, 2012)
Reported reason: Demand increase for the drug
Product Information
LIDOCAINE HCL 1% VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.1378 per ML under NDC 63323020110. Its NADAC has been published 258 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323020110
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INFILTRATION; PERINEURAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA088586FDA Approved
Before 1982
TE Code
AP
On Market Since
5/27/2010
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 1% VIAL has been published 258 times since Nov 28, 2013, and over the history we have for it it has risen 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1378 per ML |
|---|---|
| All-time high | $0.2091 (Mar 15, 2023) |
| All-time low | $0.1197 (Feb 18, 2026) |
| 52-week high | $0.1382 |
| 52-week low | $0.1197 |
| Median price | $0.1563 |
| Average price | $0.1636 |
| Largest weekly change | +33.8% (Jan 18, 2023) |
| Weeks tracked | 258 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 61% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LIDOCAINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 1% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 1% VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.1378 per ML (NDC 63323020110), effective Sep 30, 2026.
How has the price of LIDOCAINE HCL 1% VIAL changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 1% VIAL has risen 6.7%. It has been tracked across 258 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 1% VIAL?
Since Nov 28, 2013, the NADAC for LIDOCAINE HCL 1% VIAL has ranged from a low of $0.1197 (Feb 18, 2026) to a high of $0.2091 (Mar 15, 2023), with a median of $0.1563 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 1% VIAL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 1% VIAL, is $0.0542 per ML — about 61% below LIDOCAINE HCL 1% VIAL.
Who manufactures LIDOCAINE HCL 1% VIAL?
LIDOCAINE HCL 1% VIAL (NDC 63323020110) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Is LIDOCAINE HCL 1% VIAL in shortage?
Yes — NDC 63323020110 is currently listed in FDA's drug shortage database (posted Feb 22, 2012). Reported reason: Demand increase for the drug.